id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
ywZpGrQ4Eem6RhcGhj87RQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP-deficient tumors,"homozygously deleted cases, the ", caused by methylation exhibited,TextQuoteSelector,TextPositionSelector,20334,20355,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:46:02.588563+00:00
yS-UCKyMEemmAmfHklIR9A,b53nbDmi,https://europepmc.org/articles/PMC4294342/,DDK,"FH-2 cells, a full-length pMTAP-",-Myc expression plasmid and empt,TextQuoteSelector,TextPositionSelector,47712,47715,WT_GP,yes,[WT_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:27:07.644401+00:00
xLvYUKyCEemu7DP7UVovfQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,methylthioadenosine phosphorylase,nning the potential inactivated , (MTAP) that exhibited homozygou,TextQuoteSelector,TextPositionSelector,10919,10952,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:15:25.549668+00:00
xIgosrQ4Eem03A-kZw7M6Q,b53nbDmi,https://europepmc.org/articles/PMC4294342/,"MTAP protein expression and promoter methylation, no significant difference was detected in the clincopathological features, including the tumor",lation. Regarding the status of , grading and staging. By contras,TextQuoteSelector,TextPositionSelector,18168,18312,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:45:51.791244+00:00
wPq7FqyKEemu_WP--0RQqQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,CD31,umoral vessels stained with the ," endothelial marker, substantiat",TextQuoteSelector,TextPositionSelector,30959,30963,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:12:35.195568+00:00
tdTvWqyJEem8xPPjfb9jyQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,primary myxofibrosarcomas,noexpression and gene status in ,MTAP Expression (n=87)p-valueMTA,TextQuoteSelector,TextPositionSelector,18696,18721,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:05:06.858000+00:00
tEHABKyKEemR77fUJ2tL2w,b53nbDmi,https://europepmc.org/articles/PMC4294342/,Ki-67,"ing of cyclin D1, cyclin E, and ",", as well as decreased intratumo",TextQuoteSelector,TextPositionSelector,30893,30898,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:12:13.667834+00:00
rmm5WqyMEemOnosNYtgc-w,b53nbDmi,https://europepmc.org/articles/PMC4294342/,Arcturus, using the Veritas LCM machine (,) to extract genomic DNA. The MT,TextQuoteSelector,TextPositionSelector,46643,46651,WT_OG,no,[WT_OG],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:26:22.925912+00:00
prlGuLQ4Eem02q9PeIrASw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,tumors were not homozygously deleted at the MTAP,f the 29 MTAP protein-deficient ," gene (Table ​(Table1),1), methy",TextQuoteSelector,TextPositionSelector,17696,17744,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:45:01.778551+00:00
pDLDQKyNEem_YUNTLbqfuA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MATP,"3A, S1A). Therefore, we applied ",-bearing vectors and shMTAP to d,TextQuoteSelector,TextPositionSelector,22118,22122,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:33:15.289341+00:00
oTC5kKyDEem_o4NiWguIvA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MET,terized SKP2 on 5p and CDK6 and , on 7q as amplified oncogenes of,TextQuoteSelector,TextPositionSelector,13598,13601,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:21:35.129926+00:00
oDXIGqyCEem27POn6xvDVA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,Myxofibrosarcomas,r articles in PMC.Go to:Abstract, are genetically complex and inv,TextQuoteSelector,TextPositionSelector,10559,10576,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:14:24.205674+00:00
nZrHwqyMEemPqwu5leEdiw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,PIK3R1,to detect the MTAP gene dosage. , (5q13.1) was the reference gene,TextQuoteSelector,TextPositionSelector,46367,46373,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:25:54.661931+00:00
nQybnLQ4EemjB7-YBAtQFQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP-deficient sarcoma, hematoxylin-eosin (left) shows , cells (middle) and the nondetec,TextQuoteSelector,TextPositionSelector,17136,17158,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:44:45.397382+00:00
mIdeLqyJEemu-YcLHJ5qNw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP,H-1 cells exhibiting endogenous , (Figure ​(Figure3C).3C). By usi,TextQuoteSelector,TextPositionSelector,24505,24509,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:04:17.899359+00:00
ltYZ4KyDEem3Vm8R1JcS3Q,b53nbDmi,https://europepmc.org/articles/PMC4294342/,CDK6,nd characterized SKP2 on 5p and , and MET on 7q as amplified onco,TextQuoteSelector,TextPositionSelector,13589,13593,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:21:17.878680+00:00
lrubCLQ4Eem8FINgJjkfig,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP as a functional tumor,nd clinical evidence reinforces , suppressor gene exhibiting prog,TextQuoteSelector,TextPositionSelector,14651,14677,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:44:34.757565+00:00
lYo_DqyCEemu68uc7WeWlA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,tumor,"ion of inactivating mechanisms, "," suppressive function, and thera",TextQuoteSelector,TextPositionSelector,6607,6612,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:14:06.321982+00:00
k2ne9qyLEem5p5fo0z_p7g,b53nbDmi,https://europepmc.org/articles/PMC4294342/,T-cell lymphomas,", they were prone to developing ","; however, homozygous inactivati",TextQuoteSelector,TextPositionSelector,38494,38510,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:18:28.154913+00:00
jg8PXLQ5Eem8vdMIkn01Tw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,"tumor cells (Figure S3B), indicating enhanced metastatic propensity by MTAP",ignificantly increased invading , deficiency in myxofibrosarcomas,TextQuoteSelector,TextPositionSelector,26281,26356,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:51:29.707271+00:00
iUnamLQ4EemLf2tNrbU_pA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP) on 9p21.3 because whether the tumor,hylthioadenosine phosphorylase (,-suppressive role of this polyam,TextQuoteSelector,TextPositionSelector,13936,13977,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:44:12.135460+00:00
i23XQqyCEemebPf2LDP3uA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,myxofibrosarcoma,ownregulated MTAP expression in ,: A characterization of inactiva,TextQuoteSelector,TextPositionSelector,6542,6558,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:13:49.397086+00:00
hyov7KyLEemQuQe3qYjsvA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,mice ,vo tumorigenicity [9]. Although ,heterozygous for germline MTAP m,TextQuoteSelector,TextPositionSelector,38349,38354,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:18:07.610777+00:00
hvv45qyDEemTOYOs6QDQEA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,SKP2,nd cell lines and characterized , on 5p and CDK6 and MET on 7q as,TextQuoteSelector,TextPositionSelector,13574,13578,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:20:51.278323+00:00
hnIY_LQ5EemBN5Nj5SACiQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,"MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor",4342PMID: 25426549Downregulated ," suppressive function, and thera",TextQuoteSelector,TextPositionSelector,6523,6612,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:51:17.001171+00:00
hcSvzKyNEemOoNuEidpjRA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,tumorigenicity,-independent growth and in vivo , [9]. Although mice heterozygous,TextQuoteSelector,TextPositionSelector,38320,38334,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:32:24.378523+00:00
hXGIfKyKEem_W7uwfktCug,b53nbDmi,https://europepmc.org/articles/PMC4294342/,luciferase," expression (Figure 4B, C). The ", activity of MMP-9 promoter sign,TextQuoteSelector,TextPositionSelector,28286,28296,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:10:55.096219+00:00
gYUKdrQ4Eem3yV_H4zdnxQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP expression on tumor,sine. The inhibiting effects of ," growth, angiogenesis, and the i",TextQuoteSelector,TextPositionSelector,12130,12154,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:43:59.379925+00:00
fpwmSrQ5Eem032N1f4YXrQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,"MTAP deficiency in myxofibrosarcomas, and particularly that caused by homozygous deletion, negatively affects prognosis. In vitro and in vivo, MTAP may act as a tumor ","g and AMP synthesis.In summary, ","suppressor, serving antiangiogen",TextQuoteSelector,TextPositionSelector,43788,43955,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:51:03.877660+00:00
fVikqKyLEemvdvNPP8WYig,b53nbDmi,https://europepmc.org/articles/PMC4294342/,gliomas,non-small cell lung cancers and ," [13, 14, 23–26]. Instead of gen",TextQuoteSelector,TextPositionSelector,38020,38027,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:17:51.244369+00:00
f6Cx-qyCEem_TzdlmY31qw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP,4342PMID: 25426549Downregulated , expression in myxofibrosarcoma:,TextQuoteSelector,TextPositionSelector,6523,6527,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:13:29.328368+00:00
doxIyKyLEemu_mtwgTB0hw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,non-small cell lung cancers,the loss of adjoining CDKN2A in ," and gliomas [13, 14, 23–26]. In",TextQuoteSelector,TextPositionSelector,37988,38015,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:17:39.721340+00:00
dheyDqyDEempqi-7oMNDDQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,metastatic diseases,"local recurrence, and may cause "," [1–4]. However, histological ev",TextQuoteSelector,TextPositionSelector,12924,12943,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:20:22.796120+00:00
d7z4WKyNEem_O2eSywzFjw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MMP-2,e reported to increase secreted , in vitro to enhance matrix degr,TextQuoteSelector,TextPositionSelector,42380,42385,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:32:00.643773+00:00
d-xCnrQ5EemLFbP_qOV2SQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,"MTAP-inactivated myxofibrosarcomas renders this aggressive tumor subset a tumor-specific metabolic feature for use in L-alanosine therapy, which targets adenylosuccinate synthetase to abolish de novo AMP synthesis from IMP [13, 14, 30]. In vitro and in vivo, the growth inhibition of MTAP-deficient tumors", disabled methionine salvage in , by L-alanosine was partially as,TextQuoteSelector,TextPositionSelector,42683,42988,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:50:52.444695+00:00
c_XbFqyKEemhWVtTE_QmMA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,CXCL-10,"s (Table S5). Of these, CXCL-9, ",", and MMP-9 proteins were concom",TextQuoteSelector,TextPositionSelector,27711,27718,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:10:25.255798+00:00
cNiZ5LQ5EemW5GNKr2-iZQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP knockdown upregulated MMP-9 expression through the accumulation of 5′-deoxy-5′-methylthioadenosine in hepatocellular carcinomas,"5, 28]. Kiroviski reported that "," [29]. However, they neither elu",TextQuoteSelector,TextPositionSelector,41085,41217,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:50:40.721193+00:00
cASHWKyMEem3ZbPRsTiVPQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,Annexin-V,hich was evidenced by increased , and TUNEL labeling in myxofibro,TextQuoteSelector,TextPositionSelector,43091,43100,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:24:38.240369+00:00
bCktyqyKEemPqSMEXoz2Tg,b53nbDmi,https://europepmc.org/articles/PMC4294342/,CXCL-9,"andidates (Table S5). Of these, ",", CXCL-10, and MMP-9 proteins we",TextQuoteSelector,TextPositionSelector,27703,27709,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:10:12.802414+00:00
arI6DLQ5Eema3GeBpi3IUA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,"MTAP-deficient xenografts and myxofibrosarcoma specimens, MMP-9 overexpression was present in the tumor", myxofibrosarcoma cells. In the , cells and extracellular stroma ,TextQuoteSelector,TextPositionSelector,40683,40786,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:50:30.358712+00:00
anNLsKyJEem46QvpCrT6sA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,cancer,ma phenotypes regarding various , hallmarks. The stably transfect,TextQuoteSelector,TextPositionSelector,22239,22245,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:03:00.373758+00:00
aMtwyKyMEemnrHNWq-_Qig,b53nbDmi,https://europepmc.org/articles/PMC4294342/,mantle cell lymphomas,to be mitochondria-dependent in ," [24]. In addition, we demonstra",TextQuoteSelector,TextPositionSelector,43186,43207,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:24:25.756337+00:00
a0A3DqyLEemWcEO8SuiYAQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,malignancies,letion is not uncommon in human , and is primarily attributable t,TextQuoteSelector,TextPositionSelector,37838,37850,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:17:20.698924+00:00
_8mCGKyGEemR6E8-efCOxw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,PFKL, homozygous deletion at an MTAP/," ratio of < 0.2 (Table ​(Table1,",TextQuoteSelector,TextPositionSelector,17590,17594,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:45:42.340786+00:00
Z_BxtqyDEemW-9dT2pefsg,b53nbDmi,https://europepmc.org/articles/PMC4294342/,sarcoma, growth of spindle to polygonal , cells within variably myxoid st,TextQuoteSelector,TextPositionSelector,12707,12714,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:19:59.248335+00:00
ZW1vMLQ5Eem8u5MOQJX2ig,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP as a functional suppressor that governs myxofibrosarcoma pathogenesis by inhibiting tumor,indings corroborated endogenous ," proliferation, metastasis, and ",TextQuoteSelector,TextPositionSelector,40309,40403,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:50:21.420365+00:00
YF6ReKyLEemOrEPCyUCGxg,b53nbDmi,https://europepmc.org/articles/PMC4294342/,tumor,ively late genetic event in the ," progression, which may confer s",TextQuoteSelector,TextPositionSelector,37641,37646,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:17:01.995962+00:00
Y6VSdKyEEemOkdeSfGQSaQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,p21,ry Table S1). Within the 9p22.2-,".1 deletion core, the sole diffe",TextQuoteSelector,TextPositionSelector,15678,15681,WT_GP,yes,[WT_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:27:01.552641+00:00
X7u51rRkEem4PRP6A2zNYQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,S3A,against endogenous MTAP (Figure ,",C). According to matrigel invas",TextQuoteSelector,TextPositionSelector,26172,26175,WT_GP,no,[WT_GP],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T13:58:00.416586+00:00
X3CBsrQ5EembR9fSRCzlIw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,"MTAP in metastasis, which is the leading cause of sarcoma",borated the suppressive role of ,-associated mortality and critic,TextQuoteSelector,TextPositionSelector,39486,39543,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:50:11.560902+00:00
WbA8XqyHEemJ-Wetn5t6UA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,Tumor,08 Extremity23421545 Axial913514, necrosis0.4830.115 <10%19384110,TextQuoteSelector,TextPositionSelector,18934,18939,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:48:13.199216+00:00
WMYsXrQ5Eem8uveIe_XRWQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,"MTAP deficiency in myxofibrosarcomas, we characterized the biology of MTAP expression to clarify its functional effects on cancer",Given the clinical relevance of , hallmark-related phenotypes. Th,TextQuoteSelector,TextPositionSelector,38771,38900,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:50:00.371776+00:00
VlxQnKyMEemZiccHl-vlUg,b53nbDmi,https://europepmc.org/articles/PMC4294342/,IMP,lish de novo AMP synthesis from ," [13, 14, 30]. In vitro and in v",TextQuoteSelector,TextPositionSelector,42902,42905,WT_GP,no,[WT_GP],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:23:55.147577+00:00
UtSQhKyLEemnjVtOghTCFg,b53nbDmi,https://europepmc.org/articles/PMC4294342/,tumorigenesis,early phase of myxofibrosarcoma ,". However, MTAP homozygous delet",TextQuoteSelector,TextPositionSelector,37542,37555,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:16:39.601774+00:00
UseLYKyKEemaFFcRGTZr4w,b53nbDmi,https://europepmc.org/articles/PMC4294342/,ASS1,f argininosuccinate synthetase (,) caused by promoter methylation,TextQuoteSelector,TextPositionSelector,26512,26516,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:09:30.321383+00:00
UTHPZrQ5EemqXhtEzqPXfA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP-deficient hepatocellular carcinomas,erant inactivating mechanism in ," [21]. Functionally, MTAP reexpr",TextQuoteSelector,TextPositionSelector,38152,38192,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:49:47.619805+00:00
TSWPorQ5EemGizNvUpYcHw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP homozygous deletion represents a relatively late genetic event in the tumor,"sarcoma tumorigenesis. However, "," progression, which may confer s",TextQuoteSelector,TextPositionSelector,37566,37646,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:49:40.929077+00:00
TQ_pXqyMEem8yU8kaQE_YQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,adenylosuccinate synthetase,"lanosine therapy, which targets ", to abolish de novo AMP synthesi,TextQuoteSelector,TextPositionSelector,42836,42863,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:23:39.123096+00:00
SkMaXqyKEem-7aNa-PxYVw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,argininosuccinate synthetase, reported that aberrant loss of , (ASS1) caused by promoter methy,TextQuoteSelector,TextPositionSelector,26482,26510,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:09:15.969019+00:00
RhnFEKyNEem_Xq9v9c66bA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,immunodeficient,he flanks of 16 severe combined , (SCID) mice (BioLasco) and allo,TextQuoteSelector,TextPositionSelector,51811,51826,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:30:37.411289+00:00
ROWIprQ5Eem7hxPkrzVibQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,"MTAP-hypermethylated and MTAP-expressing myxofibrosarcomas, MTAP-homozygously deleted tumors",pared with the equally indolent , were often high-grade and clini,TextQuoteSelector,TextPositionSelector,37102,37194,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:49:27.056142+00:00
QFm8gqyKEem5ppd0WFb54A,b53nbDmi,https://europepmc.org/articles/PMC4294342/,S3B,ed invading tumor cells (Figure ,"), indicating enhanced metastati",TextQuoteSelector,TextPositionSelector,26301,26304,WT_GP,no,[WT_GP],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:08:58.949144+00:00
Q1vowKyJEemYv_sVrHzH-g,b53nbDmi,https://europepmc.org/articles/PMC4294342/,carcinogenesis, that may independently inhibit ," [9, 11]. We first characterized",TextQuoteSelector,TextPositionSelector,21545,21559,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:01:54.804379+00:00
PuoseKyLEemlBovULqMQ0Q,b53nbDmi,https://europepmc.org/articles/PMC4294342/,defects,caused by alternative molecular , such as small deletions of 5′ r,TextQuoteSelector,TextPositionSelector,36515,36522,WT_DS,yes,[WT_DS][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:16:05.707662+00:00
Pr1B2rQ5EemmSINIHXecAw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP-positive tumor,"tissue microarray sections, the ", cells only ranged from 10% to 2,TextQuoteSelector,TextPositionSelector,36840,36859,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:49:16.721348+00:00
OZlRnqyMEembVSO16j678g,b53nbDmi,https://europepmc.org/articles/PMC4294342/,cancer, progression involving multiple ," hallmarks [16, 30]. For instanc",TextQuoteSelector,TextPositionSelector,42286,42292,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:23:07.035538+00:00
OUqotLQ5Eem6SP-J7-M5vw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP reexpression caused decreased susceptibility to L-alanosine in the OH931 (middle) and NMFH-2 (right) cells. (C) The average tumor,"arent lines and empty controls, ", volume was significantly larger,TextQuoteSelector,TextPositionSelector,32256,32390,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:49:07.628005+00:00
MgwTJKyEEemvbDevNHoh-A,b53nbDmi,https://europepmc.org/articles/PMC4294342/,tumor suppressor gene,reinforces MTAP as a functional , exhibiting prognostic and thera,TextQuoteSelector,TextPositionSelector,14672,14693,"WT_DS,GP",no,[WT_DS][GP],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:25:38.074936+00:00
MKUo6qyOEemnwu8fa9WKWw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,Animal,ptosis assays in Methods-S5-S11., xenograftsThe animal use commit,TextQuoteSelector,TextPositionSelector,51514,51520,MIS_OG,yes,[MIS_OG][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:37:10.909447+00:00
LjQ3frQ5Eemd-EslYPbSOQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,"MTAP-reexpressing group (lower panel), which exhibited low-grade MTAP-expressing spindle cells (right). (B) L-alanosine effectively attenuated the viability of MTAP-deficient NMFH-2 and OH931 myxofibrosarcoma cell lines, and MTAP-expressing NMFH-1 cells were relatively resistant to L-alanosine, demonstrating >50% viable sarcoma",ng results were observed in the ," cells, even at 100 μM (left). U",TextQuoteSelector,TextPositionSelector,31833,32162,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:48:49.046836+00:00
KBm8uKyJEem5oeurMYUZ1A,b53nbDmi,https://europepmc.org/articles/PMC4294342/,Tumor,s did not differ prognostically., suppressive functions of MTAP i,TextQuoteSelector,TextPositionSelector,21208,21213,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:01:08.789256+00:00
Jn4jMqyMEemQuwdWyKgkyw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,ODC,gulate ornithine decarboxylase (,) and subsequently induce overpr,TextQuoteSelector,TextPositionSelector,41975,41978,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:22:34.891079+00:00
JJNH6KyKEem5pDuLuG2KXA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,CDK2, in alterations in cyclin E and , expression varied between exoge,TextQuoteSelector,TextPositionSelector,25257,25261,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:08:11.890192+00:00
IxR7qqyNEem1yNtHoay6aQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,S11, apoptosis assays in Methods-S5-,.Animal xenograftsThe animal use,TextQuoteSelector,TextPositionSelector,51510,51513,WT_GP,no,[WT_GP],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:29:38.743501+00:00
IoU0qrQ5Eem_I2O7dmfNig,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP-deficient high-grade pleomorphic sarcoma,nografts (upper panel) comprise , cells that exhibit frequent mit,TextQuoteSelector,TextPositionSelector,31562,31607,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:48:29.498145+00:00
IRXiZqyOEemQwUOzPItvvw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,breast cancer,AP reexpression in MTAP-deleted , cells may inhibit anchorage-ind,TextQuoteSelector,TextPositionSelector,38247,38260,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:36:44.704992+00:00
HyXsoKyMEemnjis_kVZR6A,b53nbDmi,https://europepmc.org/articles/PMC4294342/,ornithine decarboxylase,inine metabolism may upregulate , (ODC) and subsequently induce o,TextQuoteSelector,TextPositionSelector,41950,41973,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:22:22.682025+00:00
Htb4iqyLEemS8ad04l9HDQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,annexin V,"FH-2 cells, was validated using ",/propidium iodide staining assay,TextQuoteSelector,TextPositionSelector,34416,34425,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:15:12.586005+00:00
HE8SLLQ5Eem3zf-LOYDL7Q,b53nbDmi,https://europepmc.org/articles/PMC4294342/,tumor volume of the empty vector-transfected NMFH-2 xenografts was significantly larger than that of the MTAP,myxofibrosarcoma(A) The average ,-reexpressing counterparts (left,TextQuoteSelector,TextPositionSelector,31227,31336,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:48:18.993860+00:00
HABeBKyKEem965dpdISb-Q,b53nbDmi,https://europepmc.org/articles/PMC4294342/,cyclin E,"er, the trend in alterations in ", and CDK2 expression varied betw,TextQuoteSelector,TextPositionSelector,25244,25252,WS_GP,yes,[WS_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:07:58.396592+00:00
H1TUoqyHEemJ-INy4TUMiA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,S1B,"mitotic rate (P = 0.011, Figure ","), and marginally correlated wit",TextQuoteSelector,TextPositionSelector,18524,18527,WT_GP,no,[WT_GP],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:46:35.522681+00:00
GoonJKyHEem_MlfVPZrqwA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,S1A,"moter (Table ​(Table1,1, Figure ",). MTAP protein deficiency was s,TextQuoteSelector,TextPositionSelector,17981,17984,WT_GP,yes,[WT_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:46:27.385027+00:00
Glm3pKyEEemJ9I8AriZ8gg,b53nbDmi,https://europepmc.org/articles/PMC4294342/,CDKN2B,requently co-deleted CDKN2A and , genes still remains debated [9–,TextQuoteSelector,TextPositionSelector,14099,14105,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:24:58.732453+00:00
Fhj-hrQ5Eem5lev2a-meew,b53nbDmi,https://europepmc.org/articles/PMC4294342/,tumor suppressive function of MTAP, separate windowFigure 5In vivo , and the inhibition of L-alanosi,TextQuoteSelector,TextPositionSelector,31108,31142,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:48:08.455203+00:00
ESwAVqyEEemnfnPj5s5QBQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,CDKN2A, from the frequently co-deleted , and CDKN2B genes still remains ,TextQuoteSelector,TextPositionSelector,14088,14094,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:24:43.304489+00:00
EFElqKyOEemYyxOVIqNAYg,b53nbDmi,https://europepmc.org/articles/PMC4294342/,collagen,creased numbers of fibrohyaline , fibers and TUNEL-labeled apopto,TextQuoteSelector,TextPositionSelector,32912,32920,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:36:16.833787+00:00
DqgGiLQ5EemqBCuf2MiurA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP exhibited a significantly small average tumor,A). The xenografts reexpressing , volume from Day 7 until sacrifi,TextQuoteSelector,TextPositionSelector,30322,30372,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:47:55.914863+00:00
DKE1NKyDEemQrp-1K5x-_Q,b53nbDmi,https://europepmc.org/articles/PMC4294342/,Myxofibrosarcoma,"n, methylationGo to:INTRODUCTION", is characterized by the multino,TextQuoteSelector,TextPositionSelector,12622,12638,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:17:26.088144+00:00
Cc5AHqyHEem_qhNCLc3DYw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,tumors ,f the 29 MTAP protein-deficient ,were not homozygously deleted at,TextQuoteSelector,TextPositionSelector,17696,17703,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:45:59.038803+00:00
CDkDELQ5EemwJxdJJslSiA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP on tumor,he in vivo inhibitory effect of , growth was analyzed in NMFH-2 x,TextQuoteSelector,TextPositionSelector,30155,30168,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:47:45.242725+00:00
CAW_PqyKEemJ_5O2u4cZhQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,cyclin-dependent kinases,and G1/S-associated cyclins and ,". Among these, only cyclin D1 ex",TextQuoteSelector,TextPositionSelector,25012,25036,WS_GP,no,WS_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:07:24.857075+00:00
AlJ-mrQ5EemibQOUCZHR4w,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP reexpression inhibited growth of xenografted tumors,ults are expressed as mean ± SD.,The in vivo inhibitory effect of,TextQuoteSelector,TextPositionSelector,30066,30122,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:47:35.473818+00:00
AMo1bKyNEemnrWvVCk2eIg,b53nbDmi,https://europepmc.org/articles/PMC4294342/,lentivirus,lls were incubated with 8 mL of ," in the presence of polybrene, f",TextQuoteSelector,TextPositionSelector,49091,49101,MIS_OG,yes,[MIS_OG][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:28:40.874705+00:00
A5TAJKyMEemQukuP3k8EzA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,transcriptional factor,etastasis.Because MTAP is not a ,", it is conceivable to hypothesi",TextQuoteSelector,TextPositionSelector,41440,41462,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:21:36.190367+00:00
9heP2qyLEemKA3dnyriSTA,b53nbDmi,https://europepmc.org/articles/PMC4294342/,hepatocellular carcinomas,deoxy-5′-methylthioadenosine in ," [29]. However, they neither elu",TextQuoteSelector,TextPositionSelector,41192,41217,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:21:13.760528+00:00
9Y4QaqyMEemPrJdK1fOiNQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,viral infection,) using Lipofectamine 2000. For ,", 3 × 106 NMFH-1 cells were incu",TextQuoteSelector,TextPositionSelector,49025,49040,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:28:22.321048+00:00
9RmmVLQ4Eem8FeO16XR75w,b53nbDmi,https://europepmc.org/articles/PMC4294342/,"MTAP is linked to polyamine metabolism and adenine and methionine salvage [16, 17], examining whether MTAP inactivation promotes angiogenesis by perturbing the metabolic balance of sarcoma",myxofibrosarcomas [15]. Because ," cells is conceivable, similar t",TextQuoteSelector,TextPositionSelector,26628,26816,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:47:13.008810+00:00
96tjmKyCEem_omO8MfPcNQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MMP-9,e transcriptional repression of ,", and abrogated the susceptibili",TextQuoteSelector,TextPositionSelector,12048,12053,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:16:50.984688+00:00
7wjAfKyDEemaDvvO79nB5g,b53nbDmi,https://europepmc.org/articles/PMC4294342/,tumor suppressor gene(s),mpting the search for potential , underlying this selection press,TextQuoteSelector,TextPositionSelector,13804,13828,"WT_DS,GP",no,[WT_DS][GP],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:23:45.644648+00:00
7UEw8LQ4Eem3zPNsJDvU7g,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP modulates myxofibrosarcoma phenotypes regarding various cancer,TAP to decipher how inactivated , hallmarks. The stably transfect,TextQuoteSelector,TextPositionSelector,22178,22245,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:47:00.136639+00:00
71mJBKyCEemk-p_96eZdHg,b53nbDmi,https://europepmc.org/articles/PMC4294342/,human,d the tube-forming abilities of , umbilical venous endothelial ce,TextQuoteSelector,TextPositionSelector,11956,11961,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:16:36.919321+00:00
61YsuKyMEem3ZrPbJvzHng,b53nbDmi,https://europepmc.org/articles/PMC4294342/,Viruses,an National RNAi Core Facility. , were produced by transfecting H,TextQuoteSelector,TextPositionSelector,48758,48765,CRT_OG,no,CRT_OG,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:28:05.166167+00:00
5tLHvqyCEemYspt73CaA2w,b53nbDmi,https://europepmc.org/articles/PMC4294342/,cyclin D1,ony formation and downregulated ,. This approach also attenuated ,TextQuoteSelector,TextPositionSelector,11885,11894,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:16:22.706112+00:00
4rbBaLQ4EemFlhcYs2gSug,b53nbDmi,https://europepmc.org/articles/PMC4294342/,tumor-suppressive attributes of MTAP,olars have started noticing the , that may independently inhibit ,TextQuoteSelector,TextPositionSelector,21477,21513,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:46:42.310743+00:00
4IItTKyGEemu8Rs0MJB8pQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,nonneoplastic, of the MTAP gene. Intratumoral , cells in MFS96b account for the,TextQuoteSelector,TextPositionSelector,16775,16788,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:44:49.988555+00:00
3QZ90LQ4Eem2tk9Rncna2A,b53nbDmi,https://europepmc.org/articles/PMC4294342/,Tumor suppressive functions of MTAP,s did not differ prognostically., in myxofibrosarcomaBecause of p,TextQuoteSelector,TextPositionSelector,21208,21243,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:46:32.890104+00:00
2ZJKwKyCEemXhZOhciP8Sw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,protein deficiency,cell lines and xenografts. MTAP , (37%) was associated with MTAP ,TextQuoteSelector,TextPositionSelector,11387,11405,WT_DS,yes,[WT_DS][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T13:16:00.109143+00:00
1seFYKyJEemhWFumq4wnHQ,b53nbDmi,https://europepmc.org/articles/PMC4294342/,cyclins, in the G1- and G1/S-associated , and cyclin-dependent kinases. A,TextQuoteSelector,TextPositionSelector,25000,25007,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:06:02.011975+00:00
0L2wQqyMEemhXHsVLs2U5Q,b53nbDmi,https://europepmc.org/articles/PMC4294342/,Myc," cells, a full-length pMTAP-DDK-", expression plasmid and empty pC,TextQuoteSelector,TextPositionSelector,47716,47719,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-22T14:27:20.661170+00:00
-7TW-rQ4EemkHfORMpEHpw,b53nbDmi,https://europepmc.org/articles/PMC4294342/,MTAP governs tumor angiogenesis by the transcriptional repression of MMP-9,pen in a separate windowFigure 4,(A) The well-formed HUVEC tubes ,TextQuoteSelector,TextPositionSelector,28593,28667,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T08:47:24.189937+00:00
